Inventor · disambiguated record
Kenneth R. Chien
Also filed as: CHIEN KENNETH · CHIEN KENNETH R · CHIEN KENNETH RANDALL
31 granted patents·25 pending applications·634 citations·filing 1994–2023
97Inventor score
Files withGENENTECH INC11UNIV CALIFORNIA11PROCELLA THERAPEUTICS AB10CHIEN KENNETH R4GEN HOSPITAL CORP4
Top patents by PatentIndex Score
56 records- 0196US5534615ACardiac hypertrophy factor and uses thereforGENENTECH INC·Filed 1994·Granted Jul 9, 1996·311 cites·1 claims
- 0288US10596200B2Use of LIFR or FGFR3 as a cell surface marker for isolating human cardiac ventricular progenitor cellsPROCELLA THERAPEUTICS AB·Filed 2015·Granted Mar 24, 2020·4 cites·12 claims
- 0387US11186820B2Use of Neuropilin-1 (NRP1) as a cell surface marker for isolating human cardiac ventricular progenitor cellsPROCELLA THERAPEUTICS AB·Filed 2018·Granted Nov 30, 2021·3 cites·16 claims
- 0487US5627073AHybridomas producing antibodies to cardiac hypertrophy factorGENENTECH INC·Filed 1995·Granted May 6, 1997·34 cites·18 claims
- 0587US5571893ACardiac hypertrophy factorGENENTECH INC·Filed 1994·Granted Nov 5, 1996·44 cites·3 claims
- 0686US10612094B2Genetic markers for engraftment of human cardiac ventricular progenitor cellsPROCELLA THERAPEUTICS AB·Filed 2017·Granted Apr 7, 2020·5 cites·38 claims
- 0785US7745113B2Use of islet 1 as a marker for isolating or generating stem cellsUNIV CALIFORNIA·Filed 2004·Granted Jun 29, 2010·27 cites·15 claims
- 0885US5624806AAntibodies to cardiac hypertrophy factor and uses thereofGENENTECH INC·Filed 1995·Granted Apr 29, 1997·35 cites·8 claims
- 0983US5679545AGene encoding cardiac hypertrophy factorGENENTECH INC·Filed 1995·Granted Oct 21, 1997·28 cites·18 claims
- 1081US11401508B2Methods for isolating human cardiac ventricular progenitor cellsPROCELLA THERAPEUTICS AB·Filed 2019·Granted Aug 2, 2022·2 cites·12 claims
- 1181US10597637B2Use of jagged 1/frizzled 4 as a cell surface marker for isolating human cardiac ventricular progenitor cellsPROCELLA THERAPEUTICS AB·Filed 2015·Granted Mar 24, 2020·4 cites·5 claims
- 1280US10508263B2Methods for isolating human cardiac ventricular progenitor cellsPROCELLA THERAPEUTICS AB·Filed 2017·Granted Dec 17, 2019·4 cites·31 claims
- 1378US11725244B2Genetic markers for engraftment of human cardiac ventricular progenitor cellsPROCELLA THERAPEUTICS AB·Filed 2020·Granted Aug 15, 2023·1 cites·21 claims
- 1478US8765117B2Generation of vascularized human heart tissue and uses thereofCHIEN KENNETH R·Filed 2010·Granted Jul 1, 2014·6 cites·10 claims
- 1578US6221618B1Retinoid suppression of ventricular muscle cell hypertrophyFiled 2000·Granted Apr 24, 2001·9 cites·5 claims
- 1677US10086043B2Efficient protein expression in vivo using modified RNA (MOD-RNA)CHIEN KENNETH R·Filed 2012·Granted Oct 2, 2018·6 cites·5 claims
- 1774US12404488B2Use of neuropilin-1 (NRP1) as a cell surface marker for isolating human cardiac ventricular progenitor cellsPROCELLA THERAPEUTICS AB·Filed 2021·Granted Sep 2, 2025·0 cites·6 claims
- 1874US7193075B2Sequences upstream of the CARP gene, vectors containing them and uses thereofUNIV CALIFORNIA·Filed 2001·Granted Mar 20, 2007·2 cites·17 claims
- 1974US5723585AMethod of purifying cardiac hypertrophy factorGENENTECH INC·Filed 1995·Granted Mar 3, 1998·28 cites·9 claims
- 2074US2023383345A1Genetic markers for engraftment of human cardiac ventricular progenitor cellsPROCELLA THERAPEUTICS AB·Filed 2023·Application pending·0 cites
- 2171US7399750B2Methods for cardiac gene transferUNIV CALIFORNIA·Filed 2001·Granted Jul 15, 2008·4 cites·18 claims
- 2271US6770624B2Treatment of heart failure with growth hormoneUNIV CALIFORNIA·Filed 2001·Granted Aug 3, 2004·1 cites·21 claims
- 2370US5571675ADetection and amplification of candiotrophin-1(cardiac hypertrophy factor)GENENTECH INC·Filed 1995·Granted Nov 5, 1996·24 cites·14 claims
- 2467US12357675B2Efficient protein expression in vivo using modified RNA (mod-RNA)MASSACHUSETTS GEN HOSPITAL·Filed 2019·Granted Jul 15, 2025·0 cites·13 claims
- 2564US6451594B1Recombinant adenovirus for tissue specific expression in heartUNIV CALIFORNIA·Filed 1999·Granted Sep 17, 2002·23 cites·4 claims
- 2664US2023257714A1Methods and compositions for generating human induced mesenchymal stem cellsSMARTCELLA SOLUTIONS AB·Filed 2023·Application pending·0 cites
- 2763US2009149412A1Method for Inhibition of Phospholamban Activity for the Treatment of Cardiac Disease and Heart FailureUNIV CALIFORNIA·Filed 2008·Application pending·0 cites
- 2862US2023330264A1COMPOSITIONS AND METHODS FOR EXOSOME-MEDIATED DELIVERY OF mRNA AGENTSSMARTCELLA SOLUTIONS AB·Filed 2023·Application pending·0 cites
- 2961US2020268803A1Use of lifr or fgfr3 as a cell surface marker for isolating human cardiac ventricular progenitor cellsPROCELLA THERAPEUTICS AB·Filed 2020·Application pending·0 cites
- 3055US2006110362A1Sequences upstream of the CARP gene, vectors containing them and uses thereofUNIV CALIFORNIA·Filed 2005·Application pending·0 cites
- 3154US2011003327A1Methods for production of atrial progenitors and their differentiation into smooth muscle cells and cardiomyocytesGEN HOSPITAL CORP·Filed 2009·Application pending·0 cites
- 3254US2007150971A1Sequences upstream of the carp gene, vectors containing them and uses thereofUNIV CALIFORNIA AND CENTELION·Filed 2006·Application pending·0 cites
- 3352US2004006018A1Cardiotrophin and uses thereforGENENTECH INC·Filed 2003·Application pending·0 cites
- 3452US2012027807A1Tissue engineered myocardium and methods of production and uses thereofCHIEN KENNETH R·Filed 2009·Application pending·0 cites
- 3551US5968981ARetinoid suppression of ventricular muscle cell hypertrophyUNIV CALIFORNIA·Filed 1998·Granted Oct 19, 1999·12 cites·13 claims
- 3651US2005004058A1Sequences upstream of the carp gene, vectors containing them and uses thereofFiled 2004·Application pending·0 cites
- 3751US2019117733A1Efficient protein expression in vivo using modified rna (mod-rna)MASSACHUSETTS GEN HOSPITAL·Filed 2018·Application pending·0 cites
- 3851US2021052776A1Mesenchymal stem cells or stromal cells harboring modified rnas encoding vegf and bmp polypeptidesWITMAN NEVIN·Filed 2020·Application pending·0 cites
- 3950US2003054550A1Cardiac hypertrophy factor and uses thereforGENENTECH INC·Filed 2002·Application pending·0 cites
- 4048US2002137189A1Cardiac hypertrophy factor and uses thereforGENENTECH INC·Filed 2001·Application pending·0 cites
- 4148US2022409855A1Methods of delivering cells and therapeutic agents to organs and extravascular sitesHOLMIN STAFFAN·Filed 2022·Application pending·0 cites
- 4248US2003044982A1Method to treat hemophilia by hepatic gene transfer of factor VIII/IX with vesicle vectorFiled 2002·Application pending·0 cites
- 4348US2010166714A1Cardiovascular stem cells, methods for stem cell isolation, and uses thereofGEN HOSPITAL CORP·Filed 2007·Application pending·0 cites
- 4447US6306826B1Treatment of heart failure with growth hormoneUNIV CALIFORNIA·Filed 1997·Granted Oct 23, 2001·8 cites·20 claims
- 4547US2010210713A1Regeneration and survival of cardiac progenitors and cardiomyocytes with a stretch activated transcription factorGEN HOSPITAL CORP·Filed 2010·Application pending·0 cites
- 4646US2003166593A1Non-viral vesicle vector for cardiac specific gene deliveryFiled 2002·Application pending·0 cites
- 4744US11866475B2Modified RNA encoding VEGF-A polypeptides, formulations, and uses relating theretoMODERNATX INC·Filed 2017·Granted Jan 9, 2024·0 cites·26 claims
- 4844US2011033430A1Methods for the induction of a cell to enter the islet 1+ lineage and a method for the expansion thereofGEN HOSPITAL CORP·Filed 2008·Application pending·0 cites
- 4943US2006148742A1Polynucleotide delivery to cardiac tissueKAYE DAVID M·Filed 2005·Application pending·0 cites
- 5042US2004121942A1Method for inhibition of phospholamban activity for the treatment of cardiac disease and heart failureFiled 2003·Application pending·0 cites
Showing the top 50 of 56 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Kenneth R. Chien files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →